Chronic omega-3 or omega-6 polyunsaturated fatty acid (n-3; n-6 respectively) treatment attenuated human interleukin-1β (hIL-1β; 5.0 μg/kg)-elicited rise of circulating ACTH levels and attenuated the sickness behavior and locomotor suppression elicited by the cytokine. Furthermore, hIL-1β markedly elevated circulating levels of plasma IL-6, an effect attenuated by n-3, but not n-6 treatment. Such protective effects were not evident upon short-term (3 day) n-3 exposure. These results demonstrate that long-term administration of either n-3 or n-6 confers protection against several neuroendocrinological, immunological and behavioral actions of hIL-1β challenge, although in general the effects of n-3 were more pronounced.

, , , , ,
Journal of Neuroimmunology
Stress & Pathology Lab

Miguelez, M. (Maïa), Anisman, H, Weber, J.-M. (Jean-Michel), & Merali, Z. (Zul). (2006). Effects of acute or chronic omega-3 and omega-6 polyunsaturated fatty acid treatment on behavioral, neuroendocrine and cytokine changes elicited by exogenous interleukin-1β challenge. Journal of Neuroimmunology, 181(1-2), 19–28. doi:10.1016/j.jneuroim.2006.07.013